超越体重:探索肥胖和骨关节炎之间的联系
M C Ningtyas1, B A Ansharullah1, H Sutanto1
1Internal Medicine Study Program, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; Department of Internal Medicine, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
Semergen
|May 31, 2025
概括
肥胖症通过代谢,生物机械和炎症途径显著导致关节炎 (OA),而不仅仅是机械压力. 了解这些联系可以导致更好的肥胖引起的OA治疗.
科学领域:
- 整形外科 整形外科 整形外科
- 代谢医学是一种代谢医学.
- 类风湿病学 类风湿病学
背景情况:
- 肥胖是骨关节炎 (OA) 的主要危险因素.
- 传统的理解侧重于关节的机械应力.
- 新出现的证据表明复杂的代谢,生物机械和炎症相互作用.
研究的目的:
- 审查肥胖和骨关节炎之间的多方面的联系.
- 为了探索超越机械关节负荷的途径.
- 确定肥胖引起的OA的潜在治疗点.
主要方法:
- 对当前关于肥胖和OA的研究的文献综述.
- 对阿迪波基因 (莱普丁,维斯法丁,阿迪波内克丁,抵抗素) 的作用的分析.
- 检查肥胖的生物机械和系统性炎症影响.
主要成果:
- 肥胖通过阿迪波金,改变下肢生物力学和全身炎症影响OA.
- 阿迪波基因在关节炎的发病和进展中发挥作用.
- 减肥策略和减肥手术显示对OA产生影响.
结论:
- 肥胖引起的OA涉及超出机械压力的复杂途径.
- 阿迪波金和系统性因素对OA的发展和进展至关重要.
- 针对这些途径为OA管理提供了新的治疗途径.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
248
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
Drug Dosing: Obese Patients
226
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
226
Bone Disorders
5.1K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.1K


